Memantine is generally well tolerated, and in clinical trials, patients taking it were no more likely to stop the medication due to side effects than those taking a placebo. The most commonly reported side effects are dizziness, headache, constipation, and confusion. Most of these are mild and tend to appear early in treatment, often settling as the body adjusts.
How Memantine Works in the Brain
Memantine is prescribed for moderate to severe Alzheimer’s disease. It works by partially blocking a type of receptor in the brain involved in learning, memory, and nerve signaling. In Alzheimer’s, these receptors can become overactivated by a chemical messenger called glutamate, which damages nerve cells over time. Memantine sits inside the receptor channel and reduces that excess activity while still allowing normal signaling to occur.
This selective blocking action is what makes memantine safer than other drugs targeting the same receptors. Stronger blockers like ketamine shut down too much normal brain activity and cause severe side effects. Memantine’s gentler mechanism means it can dampen harmful overactivation without heavily disrupting the brain functions you need for everyday cognition. Still, because it does influence nerve signaling, it can cause neurological side effects like dizziness and confusion in some people.
The Most Common Side Effects
The side effects reported most often in clinical trials include:
- Dizziness: One of the most frequent complaints, especially during the first few weeks.
- Headache: Typically mild and tends to lessen over time.
- Constipation: Common enough that increasing fiber and fluid intake early on can help.
- Confusion: This can be tricky to distinguish from the underlying dementia, but new or worsening confusion after starting the medication is worth flagging.
- Drowsiness or fatigue: Some people feel more tired than usual, particularly at higher doses.
These side effects are generally mild. In the pivotal clinical trials submitted to the FDA, patients receiving memantine at doses up to 20 mg per day discontinued treatment at the same rate as patients receiving a placebo. That’s a strong signal that the drug is well tolerated across the population studied.
Psychiatric Effects to Watch For
Because memantine acts on brain receptors involved in perception and cognition, it can occasionally trigger psychiatric symptoms. The most notable are visual hallucinations and increased agitation. In documented cases, patients with Alzheimer’s developed vivid hallucinations within days of starting memantine, even at the lowest starting dose of 5 mg per day. One patient described seeing “small animals going around the room,” while another saw “people looking at her through the windows.”
These reactions are uncommon and were not flagged as side effects in the large clinical trials. But they’ve been reported in individual cases, and the pattern is clear: symptoms appeared shortly after starting the drug and resolved quickly, usually within 24 to 48 hours, once memantine was stopped. In at least one case, the hallucinations returned when the medication was restarted, confirming the link. If someone you’re caring for develops new hallucinations or noticeably worse agitation after beginning memantine, that information is important for their prescriber.
Rare but Serious Reactions
Serious side effects are uncommon but can occur. The NHS and Mayo Clinic both list several reactions that need immediate medical attention:
- Seizures: Reported rarely, but any seizure activity warrants emergency evaluation.
- Heart-related symptoms: Chest pain, fast or irregular heartbeat, sudden breathlessness, and swollen ankles or legs can signal heart failure or blood clots.
- Signs of a blood clot: Throbbing or cramping pain with redness and warmth in a leg or arm, or sudden sharp chest pain with difficulty breathing.
- Pancreatitis: Sudden severe stomach pain with nausea, vomiting, or fever.
- Severe allergic reaction: Swelling of the lips, mouth, throat, or tongue, difficulty breathing, or a widespread blistering rash. Anaphylaxis is rare but possible.
These events are listed under “incidence not known,” meaning they’ve been reported in post-marketing surveillance but are too infrequent to assign a reliable percentage. Their rarity is reassuring, but recognizing the symptoms matters because these reactions require prompt attention.
Kidney Function and Drug Buildup
Memantine is cleared from the body primarily through the kidneys. For people with mild or moderate kidney impairment, no dose adjustment is needed. But for those with severe kidney impairment, the recommended target dose is reduced to half the standard amount to prevent the drug from accumulating in the body and intensifying side effects. If you’re caring for someone with known kidney problems, their prescriber will typically check kidney function before setting the dose.
This is worth knowing because many people with Alzheimer’s are older adults who may have reduced kidney function without realizing it. Drug buildup from impaired clearance can amplify otherwise mild side effects like dizziness, confusion, and drowsiness, making them seem more severe than expected.
Managing Common Side Effects
Most of memantine’s everyday side effects respond well to simple strategies. Constipation often improves with more water, high-fiber foods, and regular movement. Dizziness is usually worst when standing up quickly, so rising slowly from a seated or lying position helps. Drowsiness may ease once the body adjusts, and taking the medication at the same time each day can help stabilize its effects.
Memantine is typically started at a low dose and increased gradually over several weeks. This slow ramp-up exists specifically to minimize side effects by giving the brain time to adapt. Skipping ahead in the schedule or doubling up on missed doses increases the chance of dizziness, confusion, and other neurological symptoms. Sticking to the prescribed titration plan is one of the most effective things you can do to reduce side effects from the start.